Multiple myeloma is a disease characterized by the proliferation of plasma cells which can lead to the abnormally high production of monoclonal...
Day: 9 May 2019
Minimal residual disease status prognostic for PFS in myeloma
Minimal residual disease status appeared prognostic for PFS at three specific time points for patients with multiple myeloma, according to results...
BCMA CAR-T bb2121 Appears to Be Safe and Effective in Multiple Myeloma
An investigational BCMA-directed chimeric antigen receptor (CAR) T-cell (CAR-T) therapy, bb2121, appeared safe and effective for previously treated...